Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_assertion type Assertion NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_head.
- NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_assertion description "[A dual inhibitor of PI3K and mTOR, PI-103, was more effective than rapamycin at suppressing proliferation of mouse pre-B-ALL and human CD19+CD34+)Ph+ ALL leukemia cells treated with the ABL kinase inhibitor imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_provenance.
- NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_assertion evidence source_evidence_literature NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_provenance.
- NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_assertion SIO_000772 18704194 NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_provenance.
- NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_assertion wasDerivedFrom befree-2016 NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_provenance.
- NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_assertion wasGeneratedBy ECO_0000203 NP687809.RA_GAC4pJmg78upK4-tuT8KBW2ExZUtqt4xqO7vVhEuFA130_provenance.